Back to search
Haematological Malignancies
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Haematological Malignancies trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Haematological Malignancies trials you may qualify forThis project aims to address invasive fungal infections in patients, by precision dosing of voriconazole based on CYP2C19 genotype testing with Bayesian dose-fo…
The outlook for patients with haematological malignancies remains challenging. It has been shown in some early cancer studies that a particular drug called Zn-D…
Aims * To identify patients that should remain admitted in hospital for more intense surveillance because of high risk for development of clinical complication…
A medication called temozolomide has been used for many years in the treatment of high-grade gliomas, which are tumours that originate in the brain. While this…
The goal of this clinical trial is to learn about the safety of drug CG009301. It also learns if drug CG009301 works to treat in Participants with relapsed or r…
Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity. Women of reproductive age are commonly offered fertilit…
Cell- and antibody-based therapies, including chimeric antigen receptor T-cell (CAR-T) therapy and bispecific antibodies, represent significant advances in the…
This study evaluates the addition of Acalabrutinib to current standard therapy of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP…